Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Current and Projected Market Size of the Digital Therapeutics Market Through 2034?
The size of the digital therapeutics market has significantly increased over the past years. It is predicted to distribute from $8.73 billion in 2024 to $10.93 billion in 2025, with a compound annual growth rate (CAGR) of 25.2%. The historic growth can be credited to elements such as the aging population and the rise in chronic diseases, the integration of digital health, the costs and efficiencies of healthcare, remote patient supervision, and the demand prompted by the pandemic.
The market for digital therapeutics is projected to witness considerable expansion in the coming years, reaching $29.56 billion in 2029, with a compound annual growth rate (CAGR) of 28.2%. The surge during this forecast period can be ascribed to the rising preference for personalized medicine, compatibility of health data, adoption of value-based care strategies, enhanced attention towards mental health and wellness, equitable access to healthcare, advancements in cybersecurity and data protection, as well as escalating demand for managing population health. Dominant trends during this period include the proliferation of IoT devices and sensors, integration of artificial intelligence in healthcare, use of wearable health technologies, enhancements in technology, and product innovation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5343&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Digital Therapeutics Market?
The projected growth of the digital therapeutics market is believed to be driven by the rising usage of smartphones and tablets, along with healthcare apps, during the forecast period. The numerous benefits of using smartphone and tablet-based healthcare apps include a decreased rate of medication errors, enabling preventive care, and improved staffing accuracy. For example, the State of Mobile Internet Connectivity Report 2023 by UK-based non-profit organization, Groupe Speciale Mobile Association (GSMA), stated that in 2022, more than half of the global population (54%) owned a smartphone. This escalating smartphone usage therefore propels the expansion of the digital therapeutics market.
Which Primary Segments of the Digital Therapeutics Market Are Driving Growth and Industry Transformations?
The digital therapeuticsmarket covered in this report is segmented –
1) By Product: Software, Devices
2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)
3) By Application: Preventive Applications, Treatment Or Care-Related Applications
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, Digital Therapeutics Software
2) By Devices: Wearable Devices, Biosensors, Digital Therapeutic Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=5343&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Digital Therapeutics Market?# Market?
North America was the largest region in the digital therapeutics market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Most Significant Market Trends in the Digital Therapeutics Market?
The rise in technological innovation forms an up-and-coming trend in the digital therapeutics sector. The key players in this market are striving to develop high-tech solutions for digital therapeutics to solidify their market standing. To illustrate, Boehringer Ingelheim, a pharmaceutical enterprise from Germany, and Click Pharmaceuticals, a prescription digital therapeutics firm from the US, have entered into an agreement to focus on the creation and sale of a digital drug for schizophrenia patients, valued over $500 million. Known as CT-155, this treatment will take the form of a mobile app, based on Click’s technological infrastructure as confirmed by the company.
View the full report here:
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report
What Parameters Are Used to Define the Digital Therapeutics Market?
Digital therapeutics (DTx) are the products that give evidence-based therapeutic treatments to patients through high-quality software applications in order to prevent, manage, or treat a medical ailment or disease.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5343
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model